PW
Pamela Wapnick sold $4K of MGX stock
Pamela Wapnick, Chief Financial Officer of Metagenomi Therapeutics, Inc. (MGX), sold 2,884 shares of MGX stock worth $4K, per an SEC Form 4 filed Jun 10, 2026.
It was an open-market sale.
The trade happened on Jun 5, 2026, 5 days before it was made public.
MGX has moved -44.2% since the trade date, from $1.28 to $0.71 (Nov 12, 2026 close).
- Traded
- Jun 5, 2026
- Disclosed
- Jun 10, 2026
- Filing delay
- 5 days
- Price since
- -44.2%
- Role
- Chief Financial Officer
- Source
- SEC Form 4